188576-49-0 Usage
Description
TERT-BUTYL 7-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE is a chemical compound that serves as a valuable reagent in the synthesis of biologically active small molecules. Its unique structure and properties make it a promising candidate for various applications in the pharmaceutical and chemical industries.
Uses
Used in Pharmaceutical Industry:
TERT-BUTYL 7-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE is used as a reagent for the preparation of biologically active small molecules. Its role in the synthesis of these molecules is crucial, as it can contribute to the development of new drugs and therapies for various medical conditions.
Used in Chemical Industry:
In the chemical industry, TERT-BUTYL 7-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE is utilized as a reagent for the synthesis of various chemical compounds. Its unique properties and reactivity make it a valuable component in the development of new materials and products with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 188576-49-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,5,7 and 6 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 188576-49:
(8*1)+(7*8)+(6*8)+(5*5)+(4*7)+(3*6)+(2*4)+(1*9)=200
200 % 10 = 0
So 188576-49-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H19NO3/c1-14(2,3)18-13(17)15-7-6-10-4-5-12(16)8-11(10)9-15/h4-5,8,16H,6-7,9H2,1-3H3
188576-49-0Relevant articles and documents
MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION
-
Paragraph 0092, (2020/12/16)
Disclosed are a class of new monocyclic β-lactam compounds, an isomer thereof or pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compounds, and the use of same in preparing drugs for treating diseases associated
DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
-
Paragraph 000571, (2019/11/04)
The invention provides dihydroisoquinoline-2(1H)-carboxamide and related compounds, pharmaceutical compositions, and their use in the treatment of medical conditions, such as cancer, and in inhibiting HPK1 activity.
ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS
-
Page/Page column 28, (2016/08/03)
The invention discloses compounds of the formula wherein A, B, X, Y and Z are defined. The compounds of the invention show activity against a range of bacteria, and are useful in the treatment or prophylaxis of a bacterial infection in an animal.